WILLINGNESS-TO-PAY TREATMENT TIME: PATIENT VERSUS NON-PATIENT PREFERENCES AND THE IMPACT OF ADAPTATION ON MONETARY VALUATION

被引：0
|
作者：
Bobinac, A. [1 ]
机构：
[1] Erasmus Univ, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.868
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP71
引用
收藏
页码：A270 / A270
页数：1
相关论文
共 34 条
  • [31] Patient-Reported Symptoms and Impact of Treatment With Osimertinib Versus Chemotherapy in Advanced Non-Small-Cell Lung Cancer: The AURA3 Trial
    Lee, Chee Khoon
    Novello, Silvia
    Ryden, Anna
    Mann, Helen
    Mok, Tony
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18) : 1853 - +
  • [32] Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial
    Poole-Wilson, P. A.
    Pocock, S. J.
    Fox, K. A. A.
    Henderson, R. A.
    Wheatley, D. J.
    Chamberlain, D. A.
    Shaw, T. R. D.
    Clayton, T. C.
    HEART, 2006, 92 (10) : 1473 - 1479
  • [33] Treatment of adolescents with Ewing sarcoma in pediatric versus non-pediatric and large or small oncology institutions: is there an impact on patient's outcome?. An analysis of GPOH Ewing trial (CESS/EICESS/EURO-EWING) data
    Dirksen, U.
    Juergens, H.
    Paulussen, M.
    Ranft, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 189 - 189
  • [34] Cost-Effectiveness Analysis of Pembrolizumab Plus Pemetrexed and Platinum Versus Chemotherapy Alone as First-Line Treatment in Metastatic Non-Squamous Non-Small Cell Lung Cancer: A Reconstruction of Partitioned Survival Model Based on Time Dependent Pricing Mechanism of Patient Assistance Program
    Cai, Yuanyi
    Hui, Wen
    Zhu, Min
    Zhang, Mingyue
    Gao, Zhixiang
    Wu, Huazhang
    FRONTIERS IN ONCOLOGY, 2021, 11
1234